Education
About Us
Working with TipRanks
Follow Us
Cronos Group (US) (CRON)
NASDAQ:CRON
CRON Stock Chart & Stats
$2.48
<$0.01(0.50%)
At close: 4:00 PM EST
$2.48
<$0.01(0.50%)
Day’s Range― - ―
52-Week Range$1.60 - $3.43
Previous Close$2.02
Volume2.24M
Average Volume (3M)3.06M
Market Cap
$1.03B
Enterprise Value$406.83M
Total Cash (Recent Filing)$824.17M
Total Debt (Recent Filing)$1.74M
Price to Earnings (P/E)28.4
Beta0.76
Next Earnings
Mar 03, 2026EPS Estimate
0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.07
Shares Outstanding382,893,280
10 Day Avg. Volume1,047,433
30 Day Avg. Volume3,058,045
Financial Highlights & Ratios
PEG Ratio-0.12
Price to Book (P/B)0.72
Price to Sales (P/S)6.53
P/FCF Ratio134.90
Enterprise Value/Market Cap0.40
Enterprise Value/Revenue3.07
Enterprise Value/Gross Profit7.31
Enterprise Value/Ebitda18.33
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Financial HealthCronos Group has robust liquidity and an asset-light model which supports its operations.
Sales GrowthGrowth was strong in multiple markets, including a 57% increase in Israel and 183% in other countries.
Bears Say
Profitability UncertaintyThe timing of profitability is unclear, and the company is not expected to achieve positive adjusted EBITDA before 2026.
Regulatory ChallengesRegulatory challenges, including unclear US federal cannabis reform and changes to the Canadian Cannabis Act, are significant factors that negatively impact the stock's valuation.
Valuation PressureCronos Group's enterprise value is slightly negative, attributed to the lack of US reform and investor restrictions, which pressures the stock compared to its peers.
Cronos Group News
CRON FAQ
What was Cronos Group (US)’s price range in the past 12 months?
Cronos Group (US) lowest stock price was $1.60 and its highest was $3.43 in the past 12 months.
What is Cronos Group (US)’s market cap?
Cronos Group (US)’s market cap is $1.03B.
When is Cronos Group (US)’s upcoming earnings report date?
Cronos Group (US)’s upcoming earnings report date is Mar 03, 2026 which is in 53 days.
How were Cronos Group (US)’s earnings last quarter?
Cronos Group (US) released its earnings results on Nov 06, 2025. The company reported $0.07 earnings per share for the quarter, the consensus estimate of $0.07 by $0.
Is Cronos Group (US) overvalued?
According to Wall Street analysts Cronos Group (US)’s price is currently Overvalued.
Does Cronos Group (US) pay dividends?
Cronos Group (US) does not currently pay dividends.
What is Cronos Group (US)’s EPS estimate?
Cronos Group (US)’s EPS estimate is 0.01.
How many shares outstanding does Cronos Group (US) have?
Cronos Group (US) has 382,893,280 shares outstanding.
What happened to Cronos Group (US)’s price movement after its last earnings report?
Cronos Group (US) reported an EPS of $0.07 in its last earnings report, expectations of $0.07. Following the earnings report the stock price went up 0.816%.
Which hedge fund is a major shareholder of Cronos Group (US)?
Currently, no hedge funds are holding shares in CRON
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cronos Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Neutral
CRON Sentiment 50%
Sector Average 69%
Sector Average 69%
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.5%
Last 30 Days ▲ 10.6%
Last 30 Days ▲ 10.6%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
30.54%
12-Months-Change
Fundamentals
Return on Equity
3.34%
Trailing 12-Months
Asset Growth
-0.48%
Trailing 12-Months
Company Description
Cronos Group (US)
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
CRON Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong performance by Cronos in Q3 2025, with record-breaking results, significant growth in Israel, and market leadership in Canada. Although there were some challenges with flower supply constraints and shipment timing issues, the overall outlook remains positive with a strong balance sheet and strategic growth initiatives in place.View all CRON earnings summariesTechnical Analysis
Canopy Growth
―
Curaleaf Holdings
―
Green Thumb Industries
―
Trulieve Cannabis
―
Cresco Labs
―
Ownership Overview
4.11% Insiders
0.59% Mutual Funds
― Other Institutional Investors
93.03% Public Companies and Individual Investors